---
title: "Freshworks (FRSH) Receives a Buy from Cantor Fitzgerald"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295327507.md"
description: "Cantor Fitzgerald analyst Matthew VanVliet reiterated a Buy rating on Freshworks (FRSH) with a $15 price target. This follows a similar Buy recommendation from Needham's Scott Berg, while Piper Sandler maintained a Hold rating on the stock."
datetime: "2026-08-09T13:25:16.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295327507.md)
  - [en](https://longbridge.com/en/news/295327507.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295327507.md)
generator: "portal-rs"
---

# Freshworks (FRSH) Receives a Buy from Cantor Fitzgerald

Cantor Fitzgerald analyst Matthew VanVliet reiterated a Buy rating on Freshworks yesterday and set a price target of $15.00.

### Claim 55% Off TipRanks

-   Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
-   Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks

VanVliet covers the Technology sector, focusing on stocks such as Salesforce, Freshworks, and Agilysys. According to TipRanks, VanVliet has an average return of -5.4% and a 40.78% success rate on recommended stocks. 

In addition to Cantor Fitzgerald, Freshworks also received a Buy from Needham’s Scott Berg in a report issued on August 5. However, on the same day, Piper Sandler maintained a Hold rating on Freshworks (NASDAQ: FRSH).

### Related Stocks

- [FRSH.US](https://longbridge.com/en/quote/FRSH.US.md)
- [CRM.US](https://longbridge.com/en/quote/CRM.US.md)
- [AGYS.US](https://longbridge.com/en/quote/AGYS.US.md)
- [PIPR.US](https://longbridge.com/en/quote/PIPR.US.md)

## Related News & Research

- [Stronger Outlook And FedRAMP Progress Might Change The Case For Investing In Freshworks (FRSH)](https://longbridge.com/en/news/296250607.md)
- [Freshworks Conference: CFO Bets on AI, Enterprise Simplicity to Drive Growth](https://longbridge.com/en/news/295875485.md)
- [Freshworks files Form 3 for Chief Product & Tech Officer Ryan Manning](https://longbridge.com/en/news/295978767.md)
- [Halozyme Buy Rating Reiterated as VYVGART Hytrulo Data Support Royalty Growth; $115 Price Target Unchanged](https://longbridge.com/en/news/296135927.md)
- [Ocular Therapeutix Earns Buy Rating as Axpaxli Differentiation and LUGANO TKI Data Bolster Confidence in Lead Asset](https://longbridge.com/en/news/296129081.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**